Literature DB >> 36009598

A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Roberto Biselli1, Roberto Nisini2, Florigio Lista3, Alberto Autore4, Marco Lastilla5, Giuseppe De Lorenzo6, Mario Stefano Peragallo7, Tommaso Stroffolini8, Raffaele D'Amelio9.   

Abstract

The environmental conditions generated by war and characterized by poverty, undernutrition, stress, difficult access to safe water and food as well as lack of environmental and personal hygiene favor the spread of many infectious diseases. Epidemic typhus, plague, malaria, cholera, typhoid fever, hepatitis, tetanus, and smallpox have nearly constantly accompanied wars, frequently deeply conditioning the outcome of battles/wars more than weapons and military strategy. At the end of the nineteenth century, with the birth of bacteriology, military medical researchers in Germany, the United Kingdom, and France were active in discovering the etiological agents of some diseases and in developing preventive vaccines. Emil von Behring, Ronald Ross and Charles Laveran, who were or served as military physicians, won the first, the second, and the seventh Nobel Prize for Physiology or Medicine for discovering passive anti-diphtheria/tetanus immunotherapy and for identifying mosquito Anopheline as a malaria vector and plasmodium as its etiological agent, respectively. Meanwhile, Major Walter Reed in the United States of America discovered the mosquito vector of yellow fever, thus paving the way for its prevention by vector control. In this work, the military relevance of some vaccine-preventable and non-vaccine-preventable infectious diseases, as well as of biological weapons, and the military contributions to their control will be described. Currently, the civil-military medical collaboration is getting closer and becoming interdependent, from research and development for the prevention of infectious diseases to disasters and emergencies management, as recently demonstrated in Ebola and Zika outbreaks and the COVID-19 pandemic, even with the high biocontainment aeromedical evacuation, in a sort of global health diplomacy.

Entities:  

Keywords:  active immunization; antibodies; biological agents; infectious diseases; passive immunization; the military; vaccines; war

Year:  2022        PMID: 36009598      PMCID: PMC9405556          DOI: 10.3390/biomedicines10082050

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  610 in total

1.  An outbreak of Q fever. I. Clinical study.

Authors:  F X FELLERS
Journal:  U S Armed Forces Med J       Date:  1952-02

Review 2.  The expanding role of therapeutic antibodies.

Authors:  Simonetta Salemi; Milica Markovic; Gabriella Martini; Raffaele D'Amelio
Journal:  Int Rev Immunol       Date:  2014-01-28       Impact factor: 5.311

3.  Use of hamsters of potency assay of Eastern and Western equine encephalitis vaccines.

Authors:  F E Cole; R W McKinney
Journal:  Appl Microbiol       Date:  1969-06

4.  [Evaluation of systematic anti-meningococcal vaccination strategy in French military recruits].

Authors:  A Spiegel; P Quenel; G Sperber; M Meyran
Journal:  Sante       Date:  1996 Nov-Dec

5.  History of malaria in the United States Naval Forces at war: World War I through the Vietnam conflict.

Authors:  C Beadle; S L Hoffman
Journal:  Clin Infect Dis       Date:  1993-02       Impact factor: 9.079

6.  Experimental infection of bobwhite quail (Colinus virginianus) with western equine encephalitis (WEE) virus.

Authors:  D M Watts; J E Williams
Journal:  J Wildl Dis       Date:  1972-01       Impact factor: 1.535

7.  Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.

Authors:  Dana L Swenson; Kelly L Warfield; Tom Larsen; D Anthony Alves; Sadie S Coberley; Sina Bavari
Journal:  Expert Rev Vaccines       Date:  2008-05       Impact factor: 5.217

8.  Immune correlates of protection for dengue: State of the art and research agenda.

Authors:  Leah C Katzelnick; Eva Harris
Journal:  Vaccine       Date:  2017-07-28       Impact factor: 3.641

9.  Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine.

Authors:  Joseph E Blaney; Andrea Marzi; Mallory Willet; Amy B Papaneri; Christoph Wirblich; Friederike Feldmann; Michael Holbrook; Peter Jahrling; Heinz Feldmann; Matthias J Schnell
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.